Æterna Zentaris to Present at BioContact in Quebec City on October 8

QUÉBEC CITY, Oct. 1 /CNW Telbec/ - Æterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its President and CEO, Juergen Engel, Ph.D., will present a corporate overview at BioContact Québec on Thursday, October 8, 2009, at 2:00 p.m. (eastern) in the Frontenac Room of the Fairmont Château Frontenac in Quebec City, Canada.

About Æterna Zentaris Inc.

Æterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.